Cargando…
Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
Non-alcoholic fatty liver disease (NAFLD) is considered to be a significant health threat globally, and has attracted growing concern in the research field of liver diseases. NAFLD comprises multifarious fatty degenerative disorders in the liver, including simple steatosis, steatohepatitis and fibro...
Autores principales: | Gupta, Haripriya, Min, Byeong-Hyun, Ganesan, Raja, Gebru, Yoseph Asmelash, Sharma, Satya Priya, Park, Eunju, Won, Sung-Min, Jeong, Jin-Ju, Lee, Su-Been, Cha, Min-Gi, Kwon, Goo-Hyun, Jeong, Min-Kyo, Hyun, Ji-Ye, Eom, Jung-A., Park, Hee-Jin, Yoon, Sang-Jun, Choi, Mi-Ran, Kim, Dong-Joon, Suk, Ki-Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945462/ https://www.ncbi.nlm.nih.gov/pubmed/35327352 http://dx.doi.org/10.3390/biomedicines10030550 |
Ejemplares similares
-
The Lactobacillus as a Probiotic: Focusing on Liver Diseases
por: Jeong, Jin-Ju, et al.
Publicado: (2022) -
T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Gebru, Yoseph Asmelash, et al.
Publicado: (2021) -
The Gut Microbiota-Derived Immune Response in Chronic Liver Disease
por: Won, Sung-Min, et al.
Publicado: (2021) -
Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease
por: Park, Eunju, et al.
Publicado: (2021) -
Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease
por: Oh, Ki-Kwang, et al.
Publicado: (2022)